Participant diversity and inclusive trial design: a meta-epidemiologic study of Canadian randomized clinical trials
Open Access
- 9 December 2025
- journal article
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 191, 112098
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Addressing health care inequities in Canadian critical care through inclusive science: a pilot tool for standardized data collectionCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2023
- Use of Participation to Prevalence Ratio for Evaluating the Representation Status of Women in Oncology Clinical TrialsJAMA Oncology, 2022
- Characterizing Demographic, Racial, and Geographic Diversity in Dementia ResearchJAMA Neurology, 2021
- Updated Guidance on the Reporting of Race and Ethnicity in Medical and Science JournalsJAMA, 2021
- Reporting of Participant Race, Sex, and Socioeconomic Status in Randomized Clinical Trials in General Medical Journals, 2015 vs 2019JAMA Network Open, 2021
- Assessment of the Inclusion of Racial/Ethnic Minority, Female, and Older Individuals in Vaccine Clinical TrialsJAMA Network Open, 2021
- Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018JAMA Oncology, 2019
- Enrollment of Older Patients, Women, and Racial and Ethnic Minorities in Contemporary Heart Failure Clinical TrialsJAMA Cardiology, 2018
- Reporting Sex, Gender, or Both in Clinical Research?JAMA, 2016
- Twenty years post‐NIH Revitalization Act: Enhancing minority participation in clinical trials (EMPaCT): Laying the groundwork for improving minority clinical trial accrualCancer, 2014